Showing results (241-250 of 695) with videos related to

Sort By:
Pageof 70
Blood|February 1, 1989
Formation of C1s-C1-inhibitor, kallikrein-C1-inhibitor, and plasmin-alpha 2-plasmin-inhibitor complexes during cardiopulmonary bypassY T Wachtfogel, P C Harpel, L H Edmunds, et al.
Archives of Biochemistry and Biophysics|September 1, 1986
Human factor XIa cleaves fibrinogen: effects on structure and functionC F Scott, R L Mentzer, A Z Budzynski, et al.
The Journal of Clinical Investigation|December 1, 1974
Immunochemical studies of plasma kallikreinA Bagdasarian, B Lahiri, R C Talamo, et al.
Circulation|July 1, 1977
Effect of clofibrate on intravascular coagulation in hyperlipoproteinemiaA C Carvalho, R S Lees, R A Vaillancourt, et al.
Thrombosis Research|December 1, 1995
Cofactors V and VIII after endotoxin administration to human volunteersE G Wyshock, A F Suffredini, J E Parrillo, et al.
The Journal of Clinical Investigation|July 1, 1977
Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikreinH L Meier, J V Pierce, R W Colman, et al.
Biochemical and Biophysical Research Communications|August 15, 1989
Cleavage of a 100 kDa membrane protein (aggregin) during thrombin-induced platelet aggregation is mediated by the high affinity thrombin receptorsR N Puri, F X Zhou, R F Colman, et al.
Blood|March 1, 1981
Effect of surfaces on fluid-phase prekallikrein activationC F Scott, E P Kirby, P K Schick, et al.
Cancer|September 15, 1985
Female adnexal tumor of probable Wolffian origin with multiple recurrences over 16 yearsR J Brescia, P C Cardoso de Almeida, A F Fuller, et al.
The EMBO Journal|April 1, 1992
p53: a transdominant regulator of transcription whose function is ablated by mutations occurring in human cancerT Unger, M M Nau, S Segal, et al.
Pageof 70